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SyntenyThe ability to regulate vascular tone is an essential cardiovascular control mechanism, with nitric oxide (NO)
assumed to be a ubiquitous smooth muscle relaxant. However, the literature contains reports of vasoconstric-
tor, vasodilator and no response to nitroergic stimulation in non-mammalian vertebrates. We examined func-
tional (branchial artery myography), structural (immunohistochemistry of skeletal muscle), proteomic
(Western analysis) and genomic (RT-PCR, sequence orthologues, syntenic analysis) evidence for endothelial
NO synthase (NOS3) inmodel and non-model ﬁsh species. A variety of nitrodilators failed to elicit any changes
in vascular tone, although a dilatation to exogenous cyclic GMP was noted. NOS3 antibody staining does not
localise to endothelial markers in cryosections, and gives rise to non-speciﬁc staining of Western blots. Abun-
dant NOS2 mRNA was found in all species but NOS3 was not found in any ﬁsh, while putative orthologues are
not ﬂanked by similar genes to NOS3 in humans. We conclude that NOS3 does not exist in ﬁsh, and that pre-
vious reports of its presence may reﬂect use of antibodies raised against mammalian epitopes.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
In mammals, nitric oxide (NO) is an important biological signalling
molecule synthesised by one of three NO synthase (NOS; EC 1.14.13.39)
isoforms: neuronal (nNOS/NOS1), inducible (iNOS/NOS2) or endothelial
(eNOS/NOS3). The endothelium of blood vessels express eNOS and on
activation NO diffuses to overlying vascular smooth muscle cells to stim-
ulate soluble guanylate cyclase, and produce cyclic GMP (cGMP)-
mediated vasodilatation (Moncada and Higgs, 2006). The importance of
eNOS in the regulation of vascular tone followed identiﬁcation of NO as
an endothelium-derived relaxing factor (EDRF) (Palmer et al., 1987)
and the ﬁnding that eNOS gene ablation in mice leads to hypertension
and bradycardia (Shesely et al., 1996). The co-expression of eNOS and
nNOS in human endothelial cells suggests that nNOS may play a
supporting role. Indeed, ablation of either eNOS or nNOS elevated base-
line blood pressure and hampered the murine baroreﬂex response
(Carvalho et al., 2006).
The existence of an EDRF similar to that found inmammals has been
demonstrated in a number of non-mammalian vertebrates such as birds
(Hasegawa and Nishimura, 1991), frogs (Knight and Burnstock, 1996),
toads (Broughton and Donald, 2002), and alligators (Skovgaard et al.,
2008). However, evidence for the presence of eNOS or that NO is the
EDRF in ﬁshes is limited. Such studies have used non-speciﬁc NOS
blockade using L-arginine analogues, L-NAME (L-nitro-arginine methyl
ester) and L-NNA (NG-nitro-L-arginine), to demonstrate NO-dependents, Faculty of Biological Sciences,
2264; fax: +44 113 343 4272.
.
rights reserved.vasodilatation.While the vasoconstriction causedbyNOS inhibitorswas
attributed to blockade of eNOS (Fritsche et al., 2000), neither the eNOS
gene nor protein has been identiﬁed in zebraﬁsh endothelium. To our
knowledge, eNOS mRNA expression has not been studied in any ﬁsh
species. Rather, immunohistochemical localisation of putative eNOS
has usedmammalian antibodies to demonstrate apparent eNOS expres-
sion (Fritsche et al., 2000; Ebbesson et al., 2005; Amelio et al., 2006;
McNeill and Perry, 2006) although extensive literature searches and
phyologenetic analyses did not yield a result in ﬁshes (Andreakis
et al., 2010; Gonzalez-Domenech and Munoz-Chapuli, 2010). Chemical
denudation of the endothelium in trout conduit artery inhibited
arginine- and adenosine-mediated vasodilatation and NO2−-production,
suggesting a role for EDRF in trout (Mustafa and Agnisola, 1998). How-
ever, in carp aorta vasodilatation using the calcium ionophore, A23187,
is endothelium-dependent but not through the actions of NO (Park
et al., 2000). Instead, endothelium-dependent vasodilatation has
been shown to be through the actions of cyclooxygenase products
in carp (Park et al., 2000) and spiny dogﬁsh Evans and Gunderson
(1998). In the eel, NO causes vasodilatation in the ventral aorta
Evans and Harrie (2001) but vasoconstriction in the branchial circu-
lation (Pellegrino et al., 2002), suggesting diverse roles for NO in the
vasculature. In the western clawed frog, Xenopus tropicalis, an eNOS
analogue protein has been identiﬁed in the kidney, heart and stomach
tissue but is not localised to blood vessels (Trajanovska and Donald,
2011). The authors concluded that the protein is more similar to
mammalian eNOS than iNOS or nNOS, and contains some, but not all,
palmitoylation and myristoylation sites characteristic of mammalian
eNOS (Trajanovska and Donald, 2011). Here, we provide evidence for
the absence of eNOS mRNA and protein in tissues from model and
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(Tetraodon nigroviridis), common carp (Cyprinus carpio) and rainbow
trout (Oncorhynchus mykiss). The ideas in this paper were ﬁrst pub-
lished in abstract form (Syeda et al., 2010).
2. Materials and methods
2.1. Animals and tissue collection
Rainbow trout (Oncorhynchus mykiss, Salmonidae) and common
carp (Cyprinus carpio Cyprinidae), ~250 g body mass, were purchased
from local farms (Leadmill trout farm, Hathersage and Ripples
Waterlife, Telford, respectively) and held in recirculating, aerated,
charcoal-ﬁltered Birmingham tap water. Spotted green pufferﬁsh
(Tetraodon nigroviridis, Tetraodontidae) were gifted by F. Mueller and
zebraﬁsh (Danio rerio, Cyprinidae) by R. Bicknell (both University of Bir-
mingham).Wistar rats (Rattus norvegicus) were purchased fromHarlan
UK Ltd (Bicester, UK). All animals were killed according to the Animals
(Scientiﬁc Procedures) Act, 1986, using Home Ofﬁce Schedule 1
methods. Trout, carp and rats were killed by stunning followed by
transecting of the brainstem, pufferﬁsh and zebraﬁshwere killed by im-
mersion in 5% (w/v) MS222. Samples were excised immediately and
snap-frozen in liquid nitrogen. Human umbilical vein endothelial cell
(HUVEC) RNA was gifted by P. Stone (University of Birmingham).
HUVEC were isolated from umbilical cords with maternal consent, and
cultured in M199, supplemented with 20% heat-inactivated fetal calf
serum, 2.5 μg/mL amphotericin B, 1 μg/mL hydrocortisone, 10 ng/mL
epidermal growth factor (all from Sigma-Aldrich) and 35 μg/mL
gentamycin (Gibco Invitrogen Compounds) until conﬂuent.
2.2. Antibodies and chemicals
The following antibodies were used: anti-eNOS, Ab1- BD Trans-
duction Laboratories (cat#610293); Ab2- Chemicon, Tenecula, USA
(cat#AB16301) and anti-nNOS, Ab3- Santa Cruz Biotechnology, USA
(cat#SC-648). All other materials were from Sigma Aldrich, UK,
unless otherwise stated.
2.3. Extraction of total RNA and reverse transcription
Total RNAwas extracted using theRNeasyMini kit (Qiagen, Valencia,
CA, USA); genomic DNA contamination was removed using the
RNase-free DNase set (Qiagen). Prior to RNA extraction, all samples
were homogenised in lysis buffer using pre-cooled 5 mm stainless
steel beads (Qiagen) and a high-speed shaker. Skeletal muscle samples
were digested with Proteinase K (Qiagen) as per the manufacturer's
instructions, prior to column separation of RNA. The quantity and qual-
ity of RNA were assessed using a NanoDrop 2000 spectrophotometer
(Thermo Scientiﬁc, Wilmington, DE, USA). RNA was stored at −80 °C
until further analysis.
2.4. Phylogenetic analysis
A selection of full-length sequences from species randomly selected
from each mammalian subclass was assembled from Ensembl (www.
ensembl.org) and the National Centre for Biotechnology Information
(NCBI; www.ncbi.nlm.nih.gov) nucleotide and protein databases.
Accession numbers of sequences for eNOS amino acids were as follows:
H. sapiens [P29474], M. mulatta [XP_002803570], P. troglodytes
[XR_02287], M. musculus [NP_032739], R. norvegicus [AAT99567],
B. taurus [NP_8513380], C. lupus familiaris [NP_001003158], E. caballus
[XP_001504700], O. aries [NP_001123373], and S. scrofa [NP_999460].
Accession numbers for eNOS nucleotide sequences were as follows:
H. sapiens [NM_00603.4], M. mulatta [XR_012468.1], P. troglodytes
[XR_02287], M. musculus [NM_008713], R. norvegicus [NM_021838.2],
B. taurus [NM_181037.2], C. lupus familiaris [NM_001003158.1],E. caballus [XM_001504649], O. aries [NM_001129901], and S. scrofa
[NM_2142951. The accession numbers for the amino acid and nucleotide
sequences for X. tropicaliswere XP_002943058 and NW_003164518, re-
spectively. The phylogeny based on multiple sequence alignments was
constructed by the widely-used neighbour-joining method, and phylo-
genetic trees created using ClustalW (Saitou and Nei, 1987; Thompson
et al., 1994), to identify sequence similarity, with the branch length of
the trees representing the fraction of mismatches at aligned positions.
Unlike computationally-intensive maximum likelihood methods,
neighbour-joining does not employ a model of sequence evolution. In-
stead, it uses a pairwise distance matrix to progressively cluster se-
quences from an initial star phylogeny; details of the clustering
heuristic are given in (Saitou and Nei, 1987). This was carried out for
allmammalian eNOS sequences. In addition, eNOS amino acid and nu-
cleotide sequences for X. tropicaliswere comparedwith human nNOS
(NP_001191147/NM_001204218.1) and iNOS (NP_000616.3/
NM_000625.4) and xenopus nNOS (ENSXETP00000048371/
ENSXETG00000022354). The statistical signiﬁcance of each tree
branch was evaluated by bootstrapping with 1000 resamples.
2.5. Myography
Blunt dissection revealed the carp efferent branchial arteries (EBA),
which were quickly removed and placed in ice-cold teleost Ringers solu-
tion (118 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM NaH2PO4, 2.5 mM
Na2HPO4, 1.9 mM NaHCO3, 2 mM CaCl2, 5.5 mM D-glucose; pH 7.8 at
12 °C) equilibratedwith air. Amodiﬁedwiremyograph (MultiMyograph
Model 610 M; Danish Myo AB) interfaced with PowerLab (AD Instru-
ments) allowed experiments on sections of vessel (approximately
2 mm) to be performed at the acclimation temperature. Passive tension
on the vessels was gradually increased and left until constant basal tone
was reached. Thereafter, pre-constriction with 50 mM KCl was used to
verify vessel viability. Agonist dose–response curves were constructed
using half decades on a log scale (Hill and Egginton, 2010). Attempts
were made to obtain a nitrodilator response using sodium nitroprusside
(SNP as sodium nitroferricyanide), 3-morpholosyndonimine (SIN-1),
S-nitroso-N-acetylpenicillamine (SNAP), and bradykinin (BK), and to
block basal nitrergic tone using L-NNA. A small number of cGMP (as
8-Bromoguanosine-3′,5′ cyclic monophosphate sodium) dose–response
curves were obtained opportunistically. Mass speciﬁc change in tension
(mN mg−1) of the agonistwas normalised to theKCl response (%KClmax).
Dilator responses were also calculated as a proportion of the
pre-constriction from which the dilator was added. Dose–response
curves were established and the pEC50 (dose at the midpoint of dilata-
tion) was calculated using R software. StatView 5.0 (SAS Institute Inc.)
was used to compare groups by ANOVA, with Fisher's PLSD post-hoc
test of signiﬁcance.
2.6. Synteny analysis
The location of the eNOS gene in mammals was identiﬁed using
the human, mouse and rat genome assemblies in Ensembl (GRCh37,
NCBIM7 and RGSC3 respectively). Syntenic regions in the zebraﬁsh
were identiﬁed using zebraﬁsh assembly Zv8.
3. PCR
eNOS and nNOS were sought in pufferﬁsh liver, zebraﬁsh liver, carp
redmuscle and trout redmuscle, using degenerate primers (eNOS: for-
ward CCCCGGCACCGGNATHGCNCC (amino acid sequence: PGTGIAP),
reverse ACAGCACCCGGTGCACYTCNSMNGC (amino acid sequence:
ACEVHRVLC); nNOS: forward GCCAAGCACGCCTGGMGNAAY, reverse
GTACTTGATGTGGTTGCADATR), and the validity of the PCR protocol
was determined by carrying out the same assay in HUVECs using a
TaqMan Gene Expression Assays primer/probe set (Applied Biosystems
Inc., USA; Hs_01574659_m1). Degenerate primers were designed
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above through CODEHOP (Consensus-Degenerate hybrid Oligonu-
cleotide Primer) to generate forward and reverse primers. cDNA
synthesis and PCR were performed on the ThermoHybaid PCR Ex-
press Thermal Cycler (Middlesex, UK), using the OneStep RT-PCR
kit (Qiagen). Ampliﬁcation for all experiments was replicated
three times. Ampliﬁcation volume was 25 μL with 50 ng RNA and
1 μg of each primer per reaction. The PCR cycling conditions were:
30 min reverse transcription (50 °C) with Sensiscript and Omni-
script reverse transcriptases, 15 min Hotstart PCR activation with
HotStarTaq®DNA polymerase, 35 cycles of 1 min denaturation
(94 °C), followed by 30 s annealing (60 °C) and 1 min extension
(72 °C), with a ﬁnal extension at 72 °C for 10 min. Agarose gel elec-
trophoresis (2%w/v) at 100 V constant voltage was carried out im-
mediately, and gel images were taken using SynGene GeneSnap
software (Cambridge, UK), to visualise PCR products.
3.1. Western blotting
Frozen samples (rat liver, trout red muscle, carp liver, zebraﬁsh
muscle and zebraﬁsh liver) were ground to ﬁne powder and homog-
enised in ice-cold RIPA buffer (150 mM sodium chloride, 1% NP-40,
1% sodium deoxycholate, 0.1% SDS, 50 mM Tris–HCl, 1 mM EDTA,
1 mM PMSF, 1 mM general protease inhibitor cocktail (Sigma),
pH 8.0), with a Potter-Elvejhem homogeniser. Samples were cen-
trifuged at 16,000 g at 4 °C (EBA12R, Global Medical Instrument,
USA), and the protein concentration in the supernatant was mea-
sured using the Bradford assay. Samples were diluted to equal
concentration in sample buffer (5% glycerol, 0.5% SDS, 3 mM
β-mercaptoethanol, 0.02% bromophenol blue and Tris–HCl, pH 6.8).
The protein was denatured at 90 °C for 3 min and 60–100 μg protein
was loaded per gel. Western blots were run on a 4% (w/v) polyacryl-
amide gel, transferred onto polyvinylidene ﬂuoride membrane with a
0.4 μm pore size, and blocked with 5% (w/v) non-fat milk in TBS/
Tween-20 buffer (20 mM Tris/HCl (pH 7.6, 137 mM NaCl and 0.1%
Tween-20) for 4 h at room temperature. Primary antibodies against
eNOS (1:2000 dilution Chemicon and Becton Dickinson)) were incu-
bated overnight at 4 °C, followed by 3 × 10 min washes in TBS and
3 × 10 min washes in TBS/0.1%(w/v) Tween-20. The membrane was
then incubated with HRP (horseradish peroxidase-conjugated) sec-
ondary antibody, 1:2000 for 1 h at room temperature, and washed
3 × 10 min in TBS/0.1% (w/v) Tween-20. Membranes were devel-
oped by applying chemiluminescence substrate (Roche Diagnostics)
and exposures made on photographic ﬁlm.
3.2. Immunohistochemistry
Trout white muscle was embedded in an inert mounting medium
(Optimum Cutting Temperature compound, BDH, UK) and frozen
onto cork discs at −160 °C. Samples were stored at −80 °C and
warmed to −20 °C for cutting into sections. Samples were cut at
10 μm and mounted onto polysine™-coated glass slides (VWR, UK),
in a Bright Clinicut Cryostat, and air-dried at room temperature.
Sections were ﬁxed with ice-cold acetone (5 min), washed 3 × 5 min
in PBS and blocked for 30 min with BSA and normal goat serum in
PBS. Tissues were stained with anti-eNOS (1:200 dilution; Chemicon)
and anti-nNOS (1:200, Santa Cruz) antibodies overnight at 4 °C and
ﬁnally washed for 3 × 5 min in PBS. Appropriate controls (secondaries
without primary antibody treatment) were included, which resulted in
blank images (results not shown). All preparations were mounted
with a mounting medium (Vector Laboratories), containing 4′,6′-
diamidino-2-phenylindole (DAPI), for identifying nuclei, and
visualised using a ﬂuorescence microscope (Zeiss Axioscop) and CCD
camera (Zeiss, MRc). Images were captured using Axiovision imaging
software.4. Results
4.1. Phylogenetic analysis
A systematic search for the NOS3 gene across all species within
Ensembl showed that no known NOS3 orthologues were present in
any ﬁsh species, and thatmost available NOS3 sequences are frommam-
mals. X. tropicalis and A. carolinensis were the closest non-mammalian
vertebrates that were allocated a NOS3 orthologue (Fig. 1). Phylogenetic
trees comparing the amino acid and nucleotide sequences of xenopus
with some mammals grouped the putative xenopus NOS3 separately
from all other species (Suppl. Fig. 1), but grouped the xenopus NOS3
closer to human NOS3 than NOS1 or NOS2 (Suppl. Fig. 2).
4.2. Myography
The various nitrodilators used (SNP, SIN-1, SNAP, BK) elicited no reac-
tion in any vessel from carp (n = 5), tested variously after pre-
constriction or from baseline tension. Similarly, L-NNA had no effect on
baseline tension. However, and surprisingly given the absence of any
response to the above nitrodilator agonists, a dilatationwas found in re-
sponse to cGMP in carp, resulting in a change in tension of 0.83 ± 0.01
mN mg−1, from a baseline of 2.18 ± 0.17mN mg−1(P b 0.05), equiva-
lent to 89 ± 38%KClmax. In contrast, the same preparations gave a po-
tent NO-dependent dilatation in trout vessels (Young & Egginton,
unpublished).
4.3. Synteny analysis
The human and mouse NOS3 genes are found on chromosomes 7
and 5, respectively (Fig. 2) and are ﬂanked by KCNH2 (potassium
voltage-gated channel, subfamily H (eag-related) gene, member 2)
and ATG9 (autophagy-related protein 9 gene). A NOS3 gene could
not be found in the zebraﬁsh genome after a thorough search using
Ensembl and PubMed, and the KCNH2 gene is located on a different
chromosome to the ATG9B in the zebraﬁsh.
4.4. PCR proﬁling
mRNA expression proﬁling of NOS3 and NOS2 in human, pufferﬁsh,
zebraﬁsh, carp and trout tissues is shown (Fig. 3). This revealed abundant
eNOS mRNA in isolated human endothelial cells but none in any of the
ﬁsh species. There was abundant NOS2 mRNA in all species, conﬁrming
the method of ampliﬁcation was suitable for the tissues used.
4.5. Western blot analysis
Western blot analysis in trout and carp muscle, and zebraﬁsh and
rat liver, comparing the polyclonal antibody that had been used to vi-
sualise NOS3 in ﬁshes in earlier studies (Ab2) with a monoclonal an-
tibody (Ab1) is shown (Fig. 4). Ab1 revealed a band in rat liver tissue,
but the band was absent in ﬁshes. Conversely, Ab2 demonstrated a
band in trout at the expected molecular weight (MW), as seen in pre-
vious studies, but there was no band in rat liver tissue. The lack of a
band for the rat liver suggests that the band seen in ﬁshes in previous
publications was a result of non-speciﬁc binding. This seems especial-
ly likely because in ﬁsh, particularly in the carp, there is a high level of
non-speciﬁc binding giving rise to 5 bands, none of which correspond
with the expected MW of NOS3 (~132 kDa).
4.6. Immunohistochemistry
Immunohistochemical staining with antibodies used to visualise
NOS3 in vessels is shown (Fig. 5). High levels of staining were seen
with NOS3 antibody, but this was not due to auto-ﬂuorescence caused
by the secondary antibody as NOS2 staining using the same secondary
Fig. 1.Maximum likelihood gene tree displaying distances between annotated eNOS (NOS3) gene orthologues in Ensembl. Note the lack of a NOS3 orthologue in ﬁsh species. There
are NOS3 orthologues in the African clawed frog (X. tropicalis), and a lizard, the Carolina Anole (A. carolinensis), but the distance evident here suggests that these may have low
identity to mammalian NOS3, therefore may be similar but not homologous to NOS3.
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lial cell marker) staining on a serial section shows that the NOS3 anti-
body binds to regions where there are no vessels, and conversely,
cannot be seen where AP staining reveals that there are vessels present
(Fig. 5D). These ﬁndings point to non-speciﬁcity of the antibodies used
in other studies that appeared to demonstrate NOS3 staining in ﬁshes
(Fritsche et al., 2000; Ebbesson et al., 2005; Amelio et al., 2006;
McNeill and Perry, 2006).
5. Discussion
This study provides genomic, immunological and functional evi-
dence that NOS3 mRNA and protein do not exist in ﬁshes. Xenopustropicalis is the closest non-mammalian vertebrate thought to express
NOS3. The putative xenopus NOS3 sequence was grouped with the
mammalian NOS3 because of its relative sequence identity to NOS3
compared with NOS1 or NOS 2, its conserved synteny with mamma-
lian NOS3, and its possession of palmitoylation and myristoylation
sites that are not characteristic of NOS1 or NOS2. However, mRNA ex-
pression of the putative xenopus NOS3 was not seen in the vascular
endothelium (Trajanovska and Donald, 2011).
The lack of a direct effect of nitrodilators on carp vascular tone may
seem a surprise given that NOS activity has been determined immuno-
histochemically using speciﬁc antibodies, and by NADPH-diaphorase
histochemistry, in the peripheral nervous system as well as throughout
the digestive tract, swim bladder and heart of the goldﬁsh Carassius
Fig. 2. Comparison of NOS3 genes and neighbouring gene loci in human, mouse and zebraﬁsh genomes. Xenopus genes shown for comparison, but chromosome location is un-
known. Arrows indicate the direction of transcription. Information collated from Ensembl genome browser.
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vasculature of Atlantic cod (Gibbins et al., 1995) and pufferﬁsh
(Funakoshi et al., 1999). In the Australian short-ﬁnned eel Anguilla
australisNOS could be found in perivascular nerves, but not in the endo-
thelium, leading to the suggestion that nNOS, but not eNOS, is present in
this species (Jennings et al., 2004). However eNOS has been reported in
dorsal aorta and vein of developing zebraﬁshDanio rerio (Fritsche et al.,
2000). In the gills of Atlantic salmon all three forms of NOS have been
demonstrated immunohistochemically (Ebbesson et al., 2005), and dif-
ferent NOS isoforms have been found in zebraﬁsh brain (Holmqvist et
al., 2000). In this study, we used the same antibody sources used in pre-
vious studies to identify the locality of eNOS in zebraﬁsh, pufferﬁsh,
rainbow trout and carp, and have demonstrated the non-speciﬁcity of
the antibodies used, and therefore cannot conﬁrm the identity of the
protein that the antibodies bound in this study. Further, we have dem-
onstrated that eNOSmRNA is probably absent, using both commercially
optimised eNOS primers and custom-made degenerate primers.
Functionally, SNP (an NO donor) has been found to exert a dilatory
effect on coronary vessels of rainbow (Small and Farrell, 1990) and
steelhead trout (Small et al., 1990). Whilst SNP also dilated steelhead
trout branchial arteries and ventral aorta, BK failed to elicit a re-
sponse, suggesting NO donors act directly on vascular smoothmuscle,
but that there is no endothelially-derived NO response (Olson and
Villa, 1991). BK also failed to dilate coronary arteries from steelhead
trout (Farrell and Johansen, 1995). However, there is some evidence
that an NO-dependent vasodilatation operating via guanylate-cyclase
is present in coronary arteries of rainbow trout (Farrell and Johansen,
1995 and dorsal aorta of Australian short-ﬁnned eel Anguilla australis
(Jennings et al., 2004). In contrast, SNP has been found to constrict
dogﬁsh ventral aorta (Evans and Gunderson, 1998). It has been postu-
lated that this may be due to formation of peroxynitrite (ONOO−), a
by-product of reactive oxygen species (ROS) and NO. In branchial
basket preparations from the eel Anguilla anguilla SNP, as well as
the ONOO− donor SIN-1 caused vasoconstriction, which could be
potentiated by incubation with the ROS scavenger superoxide
dismutase that likely reduces ONOO− formation, resulting in an in-
creased concentration of NO available to mediate constriction. Based
on a dilatation in trout aorta to SNP but not to direct application of
NO, it was concluded that SNP was activating particulate guanylate
cyclase and causing membrane hyperpolarisation, rather than actingvia soluble guanylate cyclase, as is the case with NO (Miller and
Vanhoutte, 2000). However, in carp aorta, nitrodilators such as SNP
and SIN-1 had no effect on the vascular tone, leading to the conclu-
sion that a functional NO system is not present in this species (Park
et al., 2000). This agrees with the ﬁndings of the present study,
suggesting an apparent lack of an NO-mediated dilatatory system in
this species, and therefore that this phenomenon may not be as ubiq-
uitous as previously thought. Indeed, heterogeneity of EDRF in the
coronary circulation, with effect diminishing as vessel size increases,
may be responsible for negative reports concerning the existence of
this system in arteries (Mustafa and Agnisola, 1998). However,
cGMP did produce a small dilatation in carp EBA, indicating that
part of the nitroergic pathway is present in carp.
NO can be broken down by superoxide anions (O2−), leading to a
short half life of less than 50 seconds in vitro (Gryglewski et al., 1986;
Rubanyi and Vanhoutte, 1986). However, some consider that themeth-
od of preparation of NO, choice of donor and, in in vitro experiments, the
media used, are crucial in ensuring that NO is in fact being donated
(Feelisch, 1991). For instance, SIN-1 acting as a nitrodilator produces
ONOO− rather than NO (Beckman and Koppenol, 1996) and the quan-
tity of NO released by the commonly used donor SNP may not be sufﬁ-
cient to account for its cGMP-releasing ability and associated dilatory
action (Feelisch, 1991). Cyanide has been shown to inhibit the relaxant
effects of SNP and the associated increase in cGMP levels in rat aorta
(Ignarro et al., 1981; Rapoport andMurad, 1984), althoughwith a lesser
(Rapoport and Murad, 1984) or no (Ignarro et al., 1986) inhibition on
other substances causing relaxation by cGMP-dependent mechanisms.
It has been suggested that the inhibition of SNP by cyanide is due to
chemical inactivation (Ignarro et al., 1986). As SNP releases cyanide in
addition to NO (Feelisch, 1991), it could be postulated that antagonistic
effects of these two compounds may account for the constrictive effect
of SNP sometimes observed, although in the present study this may be
discounted due to the number of nitrodonors used. Some studies have
also suggested that it is not NO itself that is EDRF, but a related com-
pound such as a nitrosothiol (Ignarro et al., 1981; Myers et al., 1990),
and based upon observed differences in its half-life a phylogenetically
attractive hypothesis has been proposed that the identity of EDRF is
species-dependent (Forstermann et al., 1984). Therefore, it is possible
that claims of a ‘NO-mediated’ response may be experimental artefacts,
instead reﬂecting a response to e.g. nitrosothiols or peroxynitrite.
Fig. 3. PCR amplicons from 35 cycles using Taqman eNOS primers, custom-made eNOS degenerate primers, and custom-made nNOS degenerate primers. C = control (water), H = human
umbilical vein endothelial cells, PF = pufferﬁsh liver, ZF = zebraﬁsh liver, CP = carp red muscle, T = trout red muscle. Top panel: Dotted arrow points to the expected size of the PCR
amplicon using the Taqman eNOS primer. Solid arrow points to the expected size of the amplicons using the degenerate eNOS primer. Bottom panel: Dotted arrow represents the expected
size for the amplicon using the nNOS degenerate primer. Solid arrow points to an unidentiﬁed amplicon.
Fig. 4.Western blots demonstrating monoclonal (Ab1; left) and polyclonal (Ab2; right)
antibody binding in rat liver (RL), trout red muscle (TM), carp liver (CL), zebraﬁsh red
and white muscle (ZM) and zebraﬁsh liver (ZL). Arrow denotes expected molecular
weight of NOS protein.
212 F. Syeda et al. / Comparative Biochemistry and Physiology, Part A 166 (2013) 207–214Immunohistochemical and western blot analysis of tissue from
non-mammalian species is currently difﬁcult. Unlike the readily avail-
able antibodies against mouse, rat and human proteins, such antibod-
ies do not exist for ﬁsh species. Consequently, the existing literature
on NOS activity relies on analyses carried out using antibodies gener-
ated against mammalian epitopes. In this study, we have demonstrat-
ed the possible pitfalls of such an approach and the necessity of
generating antibodies speciﬁc to the protein in the species concerned,
in this case NOS3, which we do not believe exists in ﬁshes. This pos-
sibility has been raised previously (Olson and Villa, 1991, and inter-
esting questions for future investigation are when the NOS3 gene
appeared during vertebrate evolution, why (or if) NOS3 activity is ad-
vantageous, which alternatives (e.g. prostanoids) permit sensitive
regulation of microvascular function in non-mammalian vertebrates,
and whether this knowledge can be exploited in mammals.
Fig. 5. Immunohistochemistry in parallel trout glycolytic muscle sections comparing polyclonal eNOS staining with Ab2 (A) to polyclonal nNOS staining with Ab3 (B). Ab2 staining
was also compared with alkaline phosphatase (AP) staining for capillaries (C vs. D). Ab2 staining produced high background whereas Ab3 staining was distinct with little back-
ground. Green arrows: Ab2 staining where there was no AP staining; white arrows: no Ab1 staining where there was AP staining; white circle: Ab1 and AP stains were adjacent
but not overlapping.
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